Blockchain Registration Transaction Record
TransCode Therapeutics Names Dr. Phillip D. Zamore to Scientific Advisory Board
TransCode Therapeutics appoints Dr. Phillip D. Zamore, a leading figure in RNA research, to its Scientific Advisory Board. The addition enhances the company's focus on RNA-targeted cancer therapy programs, marking a strategic development in the fight against metastatic disease.

This news highlights the strategic addition of a renowned expert in RNA research to TransCode's team, signaling a significant step forward in the development of RNA-targeted cancer therapies. Dr. Zamore's appointment underscores the company's commitment to advancing innovative treatments for metastatic disease.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0xe774902fb180caf175e569c0239a4bb52b8ef218f018b0b309957d01cac9daad |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | urgeSLmC-d37367a7cbe5a13a564518bcb8893c1f |